Why the study?
Debate persists regarding the association between keratoconus and mitral valve prolapse, and cross-sectional studies on their co-existing prevalence have yielded indeterminate results.
Is there a significant co-existing prevalence between Keratoconus and Mitral Valve Prolapse?
Is there a significant co-existing prevalence between Keratoconus and Mitral Valve Prolapse?
There is a statistically significant bidirectional association between mitral valve prolapse and keratoconus.
Answers are grounded in this paper and cite their sources.
Supports bidirectional association between keratoconus and mitral valve prolapse; hypothesis-generating and leaves open causal or clinical implications.
OBJECTIVE: The debate pertaining to the association between Keratoconus (KC) and Mitral Valve Prolapse (MVP) continues to occur among physicians. The results of cross-sectional studies attempting to present the co-existing prevalence of these two diseases remain indeterminate. We compiled the first meta-analysis to determine the pattern of prevalence between the two diseases. METHODS: Two separate literature searches for cross-sectional studies were performed for this metaanalysis. The first search encompassed finding literature comparing the prevalence of KC between patients with MVP and a control group. The second search pertained to finding studies comparing the prevalence of MVP patients with KC and a control group. RESULTS: Six studies reported the prevalence of MVP in patients with KC and a control group. The prevalence was 41.6% in patients with KC and 11.5% in patients without KC (OR = 7.06 [95% CI = 2.41-20.64]). There was a significant heterogeneity among the studies (I2 = 84%). Two studies showed the prevalence of KC in patients with MVP and a control group. The prevalence was 17.0% in patients with KC and 2.9% in the control group (OR = 5.07 [95% CI = 1.08-23.83]). There was no heterogeneity within the analysis (I2 = 0%). CONCLUSION: There is a statistically significant co-existing prevalence between MVP and KC. Patients with KC are more likely to present with MVP, and patients with MVP are more likely to present with KC.
No takes yet. Share an insight, caveat, or question.
Siordia et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: